Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 58 min 33 sec ago

Cyclacel Pharmaceuticals Appoints Samuel L. Barker, Ph.D., to Board of Directors

Thu, 09/11/2014 - 14:56
BERKELEY HEIGHTS, N.J., Sept. 11, 2014 -- (Healthcare Sales & Marketing Network) -- Cyclacel Pharmaceuticals, Inc. (CYCC) (CYCCP) ("Cyclacel" or the "Company") announced today the appointment of Samuel L. Barker, Ph.D., to its Board of ...
Biopharmaceuticals, Oncology, Personnel
Cyclacel Pharmaceuticals, Sapacitabine

First Surgery in Japan Using InnFocus MicroShunt(TM)

Wed, 09/10/2014 - 13:00
Shirato Eye Clinic of Tokyo is first Japanese center to use the MicroShunt for Glaucoma MIAMI, Sept. 10, 2014 -- (Healthcare Sales & Marketing Network) -- InnFocus, Inc. reported today that the first two surgeries have been conducted in Japan in a clin...
Devices, Ophthalmology
InnFocus, MicroShunt, glaucoma drainage implant

Airway Therapeutics Raises $4.6 Million in Series A Funding

Wed, 09/10/2014 - 12:55
Financing Follows FDA Orphan Designation for Startup Working to Improve Outcomes for Very Premature Infants CINCINNATI, OH--(Healthcare Sales & Marketing Network) - Airway Therapeutics, a biotechnology company working to prevent a debilitating lung cond...
Biopharmaceuticals, Venture Capital
Airway Therapeutics

Avelas Biosciences Extends Series B Financing to $7.4 Million to Support Clinical Development of Real-Time Cancer Visualization Technology

Wed, 09/10/2014 - 12:51
SAN DIEGO, Sept. 10, 2014 -- (Healthcare Sales & Marketing Network) -- Avelas Biosciences, an in vivo cancer diagnostic company dedicated to improving oncologic surgeries, announced today that it has closed on the second tranche of its Series B financing ...
Diagnostics, Oncology, Venture Capital
Avelas Biosciences

Afferent Pharmaceuticals Names Kathleen Sereda Glaub as Chief Executive Officer

Wed, 09/10/2014 - 12:49
SAN MATEO, Calif.--(Healthcare Sales & Marketing Network)--Afferent Pharmaceuticals, a leader in the development of small molecule compounds targeting P2X3 for respiratory, urologic and pain disorders, announced today that Kathleen Sereda Glaub has been na...
Biopharmaceuticals, Personnel
Afferent Pharmaceuticals

Cynosure Promotes Chris Aronson to Vice President of North American Sales

Wed, 09/10/2014 - 12:46
WESTFORD, Mass., Sept. 10, 2014 -- (Healthcare Sales & Marketing Network) -- Cynosure, Inc. (CYNO), a leader in laser- and light-based aesthetic treatments for non-invasive and minimally invasive applications, today announced the promotion of Chris Aronso...
Devices, Dermatology, Personnel
Cynosure

Harpoon Medical, Inc. Announces $3.75M Series A Financing

Wed, 09/10/2014 - 12:42
STEVENSVILLE, Md., Sept. 10, 2014 -- (Healthcare Sales & Marketing Network) -- Harpoon Medical, Inc., a medical device company focused on the development and commercialization of a minimally invasive, beating heart mitral valve repair technology, announce...
Devices, Cardiology, Venture Capital
Harpoon Medical, beating heart, mitral valve

Mylan to Acquire U.S. Rights to Arixtra(R) (fondaparinux sodium) Injection from Aspen

Wed, 09/10/2014 - 12:38
Provides Another Important and Highly Complex Injectable to Complement Mylan Institutional's Growing Portfolio in the U.S. PITTSBURGH, Sept. 10, 2014 -- (Healthcare Sales & Marketing Network) -- Mylan Inc. (MYL) today announced that its subsidiary Myla...
Biopharmaceuticals, Generics
Mylan, Arixtra, fondaparinux, Aspen Global

Cordis Corporation Launches INCRAFT(R) AAA Stent Graft System for Treatment of Abdominal Aortic Aneurysms (AAA)

Wed, 09/10/2014 - 12:33
Innovative AAA Device Offers New, Less Invasive Option for Patients and Physicians FREMONT, Calif.--(Healthcare Sales & Marketing Network)--Cordis Corporation announced today the launch of its INCRAFT® AAA Stent Graft System (INCRAFT® System), a...
Devices, Interventional, Product Launch
Cordis, INCRAFT AAA, Stent Graft, AAA, endovascular, aneurysm

Myriad myPath(TM) Melanoma Test Reduced Indeterminate Cases by 76 Percent and Changed Treatment in 35 Percent of Cases

Tue, 09/09/2014 - 12:38
SALT LAKE CITY, Sept. 9, 2014 -- (Healthcare Sales & Marketing Network) -- Myriad Genetics, Inc. (MYGN) today presented results from a pivotal clinical utility study of the Myriad myPath(TM) Melanoma test at the 2014 College of American Pathologists (CAP) ...
Diagnostics, Oncology
Myriad Genetics, myPath Melanoma

Titan Medical Inc. Appoints Dr. Dennis Fowler as Executive Vice President, Clinical and Regulatory Affairs

Tue, 09/09/2014 - 12:34
TORONTO, ONTARIO--(Healthcare Sales & Marketing Network) - Titan Medical Inc. ("Titan" or the "Company") (TSX VENTURE:TMD)(TITXF) today announced that Dr. Dennis Fowler, who currently serves as the Company's Director of Clinical Affairs...
Devices, Personnel
Titan Medical, Single Port Orifice Robotic Technology, robotic surgery

Mazor Robotics Receives China CFDA Approval for Its Renaissance Systems

Tue, 09/09/2014 - 12:30
CAESAREA, Israel--(Healthcare Sales & Marketing Network)--Mazor Robotics Ltd. (TASE: MZOR; NASDAQ GM: MZOR), a developer of innovative guidance systems and complementary products, announced today that the China Food and Drug Administration (CFDA) has appro...
Devices, Orthopaedic, Neurosurgery, Regulatory
Mazor Robotics, Renaissance system, spine surgery, robotic surgery

Tryton Medical Completes $20 Million Equity Financing

Mon, 09/08/2014 - 13:22
Funds Used to Gain U.S. Approval and Develop New Market DURHAM, N.C.--(Healthcare Sales & Marketing Network)--Tryton Medical, Inc., the leading developer of stents designed to treat coronary bifurcation lesions, today announced an initial closing of an ...
Devices, Interventional Cardiology, Venture Capital
Tryton Medical, coronary bifurcation, Side Branch Stent

Titan Spine Announces Guarantee for Its Spinal Interbody Fusion Devices

Mon, 09/08/2014 - 13:15
Spine Device Warranty Demonstrates Significant Confidence in Products MEQUON, Wis.--(Healthcare Sales & Marketing Network)--Titan Spine, a medical device surface technology company focused on developing innovative spinal interbody fusion implants, today...
Devices, Orthopaedic, Neurosurgery
Titan Spine, Endoskeleton, interbody fusion device, spine surgery

Imprimis Pharmaceuticals Appoints Healthcare Leader William H. Nelson to its Board of Directors

Mon, 09/08/2014 - 12:54
SAN DIEGO, Sept. 8, 2014 -- (Healthcare Sales & Marketing Network) -- Imprimis Pharmaceuticals, Inc. (IMMY), a specialty pharmaceutical company dedicated to delivering high quality and novel medicines to physicians and patients at accessible prices, today...
Biopharmaceuticals, Personnel
Imprimis Pharmaceuticals

AMAG Pharmaceuticals Announces Appointment of John A. Fallon, M.D. to Board of Directors

Mon, 09/08/2014 - 12:51
WALTHAM, Mass., Sept. 8, 2014 -- (Healthcare Sales & Marketing Network) -- AMAG Pharmaceuticals, Inc. (AMAG) today announced that John Fallon, M.D., senior vice president and chief physician executive at Blue Cross & Blue Shield of Massachusetts (BCBSMA), ...
Biopharmaceuticals, Personnel
AMAG Pharmaceuticals

Prospective Clinical Data On Web Aneurysm Embolization System Demonstrate Excellent Safety And High Rate Of Stable Occlusion In Difficult To Treat Aneurysms

Mon, 09/08/2014 - 12:48
ALISO VIEJO, Calif. and NICE, France, Sept. 8, 2014 -- (Healthcare Sales & Marketing Network) -- Sequent Medical, Inc. announced today the presentation of results from WEBCAST, a prospective study of the WEB™ Aneurysm Embolization System at the European S...
Devices, Interventional, Neurology
Sequent Medical, WEB Aneurysm, Embolization, MicroBraid

Successful Completion of Phase III Program for Teva’s Reslizumab Two More Phase Iii Studies Support the Benefits of Reslizumab Treatment in Asthma Patients with Eosinophilia

Mon, 09/08/2014 - 12:42
New Phase III data presented at European Respiratory Society Congress (ERS) builds on recent exacerbation reduction data, creating a special efficacy profile for reslizumab Reslizumab shown to significantly improve lung function and asthma control F...
Biopharmaceuticals
Teva Pharmaceutical, reslizumab, asthma, Eosinophilia

Cynosure Acquires Assets of RF Medical Device Manufacturer Ellman International, Inc.

Mon, 09/08/2014 - 12:37
Deal Complements Cynosure's Platform with Radiofrequency Energy Sources and Accessory Products for Aesthetic and Surgical Indications; Management to Discuss Transaction in Conference Call at 9:00 a.m. ET today WESTFORD, Mass., Sept. 8, 2014 -- (Healt...
Devices, Dermatology, Mergers & Acquisitions
Cynosure, Ellman International

Aurora Spine Appoints National Sales Manager in the UK

Fri, 09/05/2014 - 13:22
CARLSBAD, CALIFORNIA--(Healthcare Sales & Marketing Network) - Aurora Spine Corporation (TSX VENTURE:ASG) announced today the appointment of Mike Coupland as National Sales Manager in the United Kingdom (UK). Mr. Coupland will manage Aurora's UK sales effo...
Devices, Orthopaedic, Neurosurgery, Personnel
Aurora Spine

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong